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Abstract 
Background: The complications of clinical metastatic disease are responsible for the majority of breast cancer related 
deaths, and fewer therapies substantially prolong survival. Nitidine chloride (NC), a natural polyphenolic compound, 
has been shown to exhibit potent anticancer effects in many cancer types, including breast cancer. The epithelial-
mesenchymal transition (EMT) and the acquisition of cancer stem cells (CSCs)-like properties emerge as critical steps 
in the metastasis of human cancers. However, the effects of NC on the EMT and the CSCs-like properties in breast 
cancer cells, and the underlying molecular mechanisms are not fully understood.
Results: In the present study, MDA-MB-468 and MCF-7 cancer cells were treated with NC. Scratch and Transwell 
assays were performed to determine whether NC could attenuate the migratory and invasive capability of cancer 
cells; Mammosphere formation and flow cytometry analysis were performed to confirm that NC decreased CSCs-
like phenotype; RT-PCR and western blot analysis were used to examine the expression level of EMT and CSC related 
markers in both cells. Mechanistically, NC could inhibit the components of Hedgehog pathway (smoothened, 
patched, Gli1 and Gli2), subsequently inhibited the expression of Snail, Slug and Zeb1, which were correlated with 
the significant changes of the expression of EMT related markers (N-cadherin, E-cadherin, and Vimentin) to reverse 
EMT. On the other hand, NC could also inhibit the expression of CSCs related factors such as Nanog, Nestin, Oct-4 and 
CD44 via Hedgehog pathway. Furthermore, transforming growth factor-β1 (TGF-β1)-induced increment of EMT and 
CSCs properties could be reversed by NC.
Conclusions: Taken together, these data indicated that NC suppressed breast cancer EMT and CSCs-like properties 
through inhibiting Hedgehog signaling pathway. Our study suggested that NC may be a potential anticancer agent 
for breast cancer.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Despite advances have been made in breast cancer treat-
ment over the last decades, this malignancy is still the 
common cause of cancer-related deaths among females 
worldwide. Presently, breast cancer has been one of the 
most commonly diagnosed cancers, with approximately 
1.7 million new patients in 2012, accounting for 25 % of 
all women cancer cases [1]. And the majority of cancer 
deaths can be due to development of related metastatic 
disease. In spite of the initial effectiveness of conventional 
therapies, recurrence and the emergence of metastases 
are major causes of therapeutic failure in cancer patients. 
The relatively high relapse and metastasis rate of patients 
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with aggressive forms of breast cancer are attributed to a 
small population of cancer stem cells (CSCs) or tumor-
initiating cells (TICs) residing within tumor. Recently, 
CSCs, together with epithelial mesenchymal transition 
(EMT)-type cells which shares similar molecular char-
acteristics with CSCs, have been demonstrated to play 
vital roles in tumor metastasis. They also contribute to 
radioresistance and chemoresistance as reported in sev-
eral malignancies such as breast cancer. Therefore, novel 
adjuvant agents with complete efficacy and low toxicity 
are directed to be applied in the treatment of metastatic 
breast cancers and improve patient survival.
Nitidine chloride (NC), which is a natural phytochemi-
cal alkaloid, is isolated from the root of Zanthoxylum 
nitidum, and possesses pleiotropic anticancer capabili-
ties in different cancer types, including breast cancer. It 
has been found that NC exhibits several types of phar-
macologic properties closely related to health therapies, 
including antimalarial [2], anti-inflammatory [3], anti-
fungal [4], antiangiogenesis [5], and anticancer activity 
[6]. It has been reported that NC can inhibit the ability of 
cellular migration and invasion in breast cancer through 
suppressing the c-Src/focal adhesion kinase (FAK)-asso-
ciated signaling pathway. Our previous study has demon-
strated that NC can cause cell cycle arrest and apoptosis 
by regulating cyclin-CDK cascade, caspase 3 and PARP 
cleavages in breast cancer cells [7]. Interestingly, the 
combination of NC and doxorubicin has a synergistic 
inhibitory effect on cellular proliferation of breast cancer 
[7]. However, the underlying mechanism of NC in regu-
lating cancer cellular EMT and CSCs-like phenotype are 
little investigated.
Metastasis occurring involves a complex and multistep 
process, including cellular invasion from primary tumors 
into the circulation, their migration to distant organs, 
then adhesion to endothelial cells and infiltration into tis-
sues. Accumulating evidences suggest that EMT can play 
a critical role in tumor invasion and metastasis by equip-
ping these cells with a more motile and invasive pheno-
type [8–10]. Several signaling pathways like the TGF-β, 
Wnt, Notch and Hedgehog pathways [11, 12], have been 
involved in mediating these transitions, through regulat-
ing the expression of crucial EMT-related transcription 
factors, such as Snail, ZEB and Twist families [13, 14]. In 
recent years, there has been growing studies that induc-
tion of EMT phenotype by different factors results in the 
enrichment of cells with stem-like characters, termed 
cancer stem cells [15–17]. The population of CD44+/
CD24−/low has emerged as one of the key markers for iso-
lated breast cancer stem cell, which have been reported 
to be associated with secondary metastasis and resist-
ance to radiotherapy on breast cancer tissues [18, 19]. 
The complex relationship between EMT and stemness 
phenotype has acquired huge interest in the field of can-
cer research.
Here, we showed that NC could suppress breast 
cancer metastasis. And the anti-cancer effects of NC 
were due to decrease of the Hedgehog signaling. Sub-
sequently, NC showed the inhibitory effect on the 
expression of transcription factors (Snail, Slug and 
Zeb1), and then reversed EMT with decreased mesen-
chymal markers (i.e., N-cadherin and Vimentin) and 
increased epithelial markers (E-cadherin), meanwhile 
it inhibited the expression of pluripotency maintaining 
factors including Nanog, Nestin and Oct-4, and then 
suppressed CD44 expression and CSC phenotypes, all 
of which were crucial for distant metastasis of breast 
cancer.
Methods
Cell culture and NC treatment
Breast cancer cell lines MCF-7 and MDA-MB-468 
were obtained from American Type Culture Collection 
(ATCC, Manassas, VA, USA), and were routinely cul-
tured in DMEM medium (GIBCO Laboratories, Grand 
Island, NY, USA) supplemented with 10 % FBS (Haoyang 
biological manufacture, Tianjin, China), 100 U/ml peni-
cillin and 100 mg/ml streptomycin. Nitidine chloride was 
obtained from Tauto Biotech (Shanghai, China) and dis-
solved in dimethyl sulfoxide (DMSO). Epidermal growth 
factor (EGF), basic fibroblast growth factor (bFGF), and 
bovine insulin were obtained from Sigma Aldrich (St. 
Louis, MO, USA). B27 supplement (50×) was purchased 
from Gibco. For NC treatment, stock solution (5  mM 
in DMSO) was added into culture medium to achieve 
appropriate concentration (1 or 2.5 μM), and then incu-
bated with cells, whereas DMSO solution without NC 
was used as a control.
Reagents and antibodies
The Hedgehog inhibitor, cyclopamine was purchased 
from Selleck Chemicals (Houston, USA). TGF-β1was 
purchased from sigma (St.Louis, MO, USA). Primary 
antibodies against E-cadhein, N-cadherin, Snail, and 
Vimentin were procured from cell signaling technology 
(Beverly, MA, USA). The anti-CD44, anti-Gli-1, anti-
Gli-2, anti-Patched and anti-Smoothened antibodies 
were obtained from Immuno-way (Newark, DE, USA). 
Anti-β-actin was purchased from Dako Corp (Carpin-
teria, CA, USA). The secondary horseradish peroxidase 
(HRP)-linked antibodies were obtained from Tiangen 
Biotech CO., LTD (Beijing, China).
Cell proliferation assay by MTT assay
The effect of NC on proliferation of MDA-MB-468, 
MCF-7 parental cells and mammospheres was examined 
Page 3 of 13Sun et al. Cell Biosci  (2016) 6:44 
by MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetra-
zolium bromide] assay. Cells (2.5  ×  103 per well) were 
seeded in 96-well plates and allowed to grow for 24  h. 
Then NC or DMSO (vehicle control) was added after plat-
ing onto adherent cells at specified concentrations. After 
indicated time of treatment, 20 μl of MTT solution (5 mg/
ml; Sigma, St. Louis, MO) was added to each well and 
incubated for 4 h at 37 °C. The MTT formazan crystal was 
then dissolved in DMSO, and the absorbance was meas-
ured by a Microplate reader (Bio-Rad 680, Bio-Rad Labo-
ratories, Hercules, CA) at a wavelength of 570 nm.
In vitro scratch assay
Cell migratory ability was detected by a wound-healing 
assay. The MDA-MB-468 and MCF-7 cells were seeded in 
24-well plates (1.0 × 105 cells/500 μl). After the cells grew 
to 90–100 % confluence, a 200 μl sterile pipette tip was 
used to produce a wound line between the cells. Cellular 
debris was removed by washing with PBS. The wounded 
monolayers were then incubated with NC or vehicle for 
24 h. The distance between two cell edges were analyzed 
by ImageJ software.
Migration and invasion assay
The migration and invasion of breast cancer cells were 
performed in transwell chambers (24-well, 8  μm pore 
size with polycarbonate membrane; Corning Costar, 
Lowell, MA, USA). The invasion assay was performed 
in the same way as the migration assay except that the 
membrane was coated with matrigel (BD Biosciences, 
Bedford, MA, USA). Briefly, the polycarbonate mem-
branes were coated with 40 ml matrigel at 37 °C for 2 h 
to form a reconstituted basement membrane. Seven hun-
dred microlitres of the medium with 20 % FBS was added 
to the lower well of each chamber and 1 ×  105 of cells 
resuspended in the serum-free medium were added to 
the upper inserts. The total number of cells adhering to 
the lower surface of the membrane was acquired in six 
representative fields.
Spheroid formation
Tumorsphere formation assay was carried out as previ-
ously described [20]. Briefly, suspension single cells were 
plated at a density of 10,000  cells/ml and grown in a 
serum-free DMEM/F12 medium (Gibco-BRL, Rockville, 
IN, USA), supplemented with 5  μg/ml bovine insulin, 
20 ng/ml EGF, 20 ng/ml bFGF, and 1 × B27 supplement. 
Cells were grown for 7–14 days, and medium was replen-
ished every 3–4  days. Tumorsphere volume was calcu-
lated using the following formula: (length  ×  width2)/2. 
The numbers of spheres with diameter over 50 μm were 
counted through a microscope.
Flow cytometry analysis
Cell surface markers were detected by flow cytometry anal-
ysis following previous protocols [21]. Briefly, cells were 
harvested and resuspended with Pharmingen Stain Buffer 
to a final concentration of 2 × 107 cells/ml. Then, fluoro-
chrome conjugated mouse anti-human CD44 or CD24 in 
combination with their respective isotype controls was 
added and incubated for 20  min on ice, protected from 
light. After being washed twice, the cells were resuspended 
in 0.5  ml Stain Buffer and analyzed by a FACScan flow 
cytometer (Becton–Dickinson, Franklin lakes, NJ, USA).
Quantitative real‑time PCR
Total RNA was extracted from cultured cells with TRI-
zol reagents (Invitrogen) according to the manufactur-
er’s protocol. Briefly, Total RNA was reverse transcribed 
to cDNA by using Prime Script RT reagent Kit (Takara, 
Dalian, China). Real-time PCR was performed with the 
SYBR green Premix Ex Taq II (Takara) with Applied Bio-
systems Step One Plus Real-Time PCR System (Applied 
Bio-systems, Carlsbad, CA, USA). Relative quantifica-
tion analysis was performed using the comparative C (T) 
(2(−ΔΔCT)) method. The following gene-specific prim-
ers were used. GAPDH (5′-AGA AGG CTG GGG CTC 
ATT TG-3′, 5′-AGG GGC CAT CCA CAG TCT TC-3′); 
Snail (5′-ACC CCA CAT CCT TCT CAC TG-3′, 5′-TAC 
AAA AAC CCA CGC AGA CA-3′); Slug (5′-ACA CAC 
ACA CAC CCA CAG AG-3′, 5′-AAA TGA TTT GGC 
AGC AAT GT-3′); Zeb1 (5′-GCA CAA CCA AGT GCA 
GAA GA-3′, 5′-CAT TTG CAG ATT GAG GCT GA-3′); 
E-cadherin (5′-GAA GCA CAG AAT CCC CAA GTG-
3′, 5′- GGC GTG TTT GTC TTC CAT TTC-3′); Vimen-
tin (5′-GAC AAT GCG TCT CTG GCA CGT CT-3′, 
5′-TCC GCC TCC TGC AGG TTC TT-3′); Twist (5′-
CAA GTC TGC AGC TCT CGC CA-3′, 5′-CCA ACG 
GCT GGC GCA CAC-3′); Nestin (5′-AAC AGC GAC 
GGA GGT CTC TA-3′, 5′-TTC TCT TGT CCC GCA 
GAC TT-3′); Nanog (5′-ACC TAC CTA CCC CAG CCT 
TT-3′, 5′-CAT GCA GGA CTG CAG AGA TT-3′); Oct4 
(5′-GGA CCA GTG TCC TTT CCT CT-3′, 5′-CCA 
GGT TTT CTT TCC CTA GC-3′); Smoothened (5′-TCG 
CTA CCC TGC TGT TAT TC-3′, 5′-GAC GCA GGA 
CAG AGT CTC AT-3′); Gli1 (5′-CTG GAT CGG ATA 
GGT GGT CT -3′, 5′-CAG AGG TTG GGA GGT AAG 
GA-3′).
Western blot analysis
Cell indicated were treated with NC for 48  h, and then 
total cellular protein lysates were prepared with radio 
immunoprecipitation assay buffer (PBS, 1  % NP40, 
0.1 % SDS, 5 mM ethylenediaminetetraacetic acid, 0.5 % 
sodium deoxycholate, 1  mM sodium orthovanadate) 
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containing proteinase inhibitors. A total of 30–40  μg of 
protein was separated by SDS-PAGE and transferred to a 
polyvinylidene difluoride membrane (Millipore, Bedford, 
MA, USA). Following blocking with 5  % non-fat milk, 
the membranes were incubated overnight at 4  °C with 
the primary antibodies. After being washed with TBST, 
membranes were incubated with secondary antibodies at 
room temperature for 2 h, and the proteins were detected 
by a chemiluminescence system (ECL kit). Loading dif-
ferences were normalized using a monoclonal β-actin 
antibody.
Statistical analysis
All assays were repeated in triplicates in three independ-
ent experiments, and quantitative data were presented 
as mean ± SD. The differences between two groups were 
compared by Student’s t test. All error bars represent 
the S.E. of three experiments. In all cases, P < 0.05 was 
considered statistically significant. All statistical analyses 
were performed using SPSS 18.0 (SPSS Inc., Chicago, IL, 
USA).
Results
NC inhibited the proliferation of breast cancer parental 
cells and mammospheres
The proliferation-inhibitory effects of NC with different 
concentrations on MDA-MB-468 and MCF-7 cell lines 
were investigated by MTT assay. Both results indicated 
NC-induced inhibition of MDA-MB-468 and MCF-7 
parental cells proliferation in a dose-dependent man-
ner at 48 h (Fig. 1a, b). To determine whether NC could 
inhibit the viability of cancer stem cells, MDA-MB-468 
and MCF-7 mammospheres were used as a model of 
breast CSCs. As shown in Fig.  1c, d, the viable mam-
mospheres at 24, 48, and 72  h after the treatment with 
NC (1.0  μM) were decreased time-dependently. How-
ever, mammospheres showed more resistance to the NC-
induced inhibition effect compared to parental cells.
NC inhibited the migration and invasion of breast cancer 
cells
The effect of NC on cellular motility of breast cancer 
was determined by using wound-healing assay. Serum 
Fig. 1 The effect of NC on breast cancer parental cells and mammospheres viability was measured using MTT based. a, b NC had effects on cell 
proliferation of breast cancer MDA-MB-468 and MCF-7 parental cells and mammospheres in a concentration dependent manner. However, sphere-
derived cells showed relative resistance to NC compared to parental cells. c, d Both Parental cells and mammospheres were treated with indicated 
concentrations of NC. However, no obviously cell death was observed by NC at 1.0 μM for 24, 48 and 72 h in MTT assay. *P < 0.05 compared with 
the control. The data are presented as the mean ± SD of three separate experiments
Page 5 of 13Sun et al. Cell Biosci  (2016) 6:44 
starved MDA-MB-468 and MCF-7 cells in the control 
group exhibited marked cell migration in the wound 
area after 48 h wounding, while the cells treated with 
NC (1.0  μM) showed relative delays in wound clo-
sure (Fig. 2a, b). To examine its potential anti-invasive 
effects, the ability of invasion was analyzed in MDA-
MB-468 and MCF-7 cells treated with NC. As shown 
in Fig. 2c and d, the average number of cells invading 
into the lower chamber decreased accordingly, when 
the NC concentration increased from 0 to 1.0  μM. 
Since 1.0  μM of NC decreased the cellular migratory 
and invasive capability of breast cancer effectively 
without obvious cytotoxicity (Fig. 1a, b), we chose this 
concentration for further investigation. This finding 
revealed that NC might be an effective inhibitor of cel-
lular migration and invasion of breast cancer.
NC inhibited EMT (epithelial‑mesenchymal transition) 
in breast cancer cells
It is believed that acquiring the migratory characteris-
tics of a mesenchymal-like state can enhance the invasive 
capabilities of cancer cells. EMT is crucial for the inva-
sion and metastasis of breast cancer, and we have firstly 
showed that NC could inhibit cell migration and invasion 
of breast cancer MDA-MB-468 and MCF-7 cells, which 
was accompanied with upregulation of epithelial marker 
E-cadherin and downregulation of mesenchymal mark-
ers N-cadherin and Vimentin at the mRNA level (Fig. 2f ). 
As expected, NC could also inhibit the expression of the 
transcription factors Snail, Slug and Zeb-1 at the mRNA 
level (Fig. 2f ).
The protein expression of E-cadherin, N-cadherin, 
Vimentin and Snail in the breast cancer cells subject 
Fig. 2 NC attenuates the migratory capacity and EMT of breast cancer cells. a, b MDA-MB-468 and MCF-7 cells were treated with the indicated 
concentrations of NC for 48 h. NC significantly inhibited the migration of cells into the denuded areas. The MDA-MB-468 and MCF-7 cells were 
treated with increasing concentrations of NC (0, 1.0 μM) for 48 h. c, d Photos of the invasive and migration were taken under a microscope with a 
200× objective. e, f Both cell types were treated with 0, 1, or 2.5 μM NC for 48 h and then Protein and mRNA expression levels of EMT-related genes 
were detected. *P < 0.05 or **P < 0.05 compared with the control group
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to NC at 48  h were evaluated by Western blotting. As 
shown in Fig. 2e, NC treatment could also influence the 
expression of EMT-related factors at protein levels, and 
this trend was consistent with the mRNA results.
NC decreased the CSCs‑like properties of breast cancer 
cells
Development of EMT involves acquisition of stem cell-
like features, including the surface marker expression 
of stem cells, nonadherent growth, as well as changes in 
expression of cell-surface glycoproteins [15]. The sub-
population of CD44+/CD24−/low cells has been shown to 
exhibit cancer stem-like properties, and these cell surface 
markers have been used as functional markers for sort-
ing cancer stem cells from parental cell lines [22]. In our 
present study, NC significantly suppressed the number 
of MDA-MB-468 and MCF-7 cells expressing CD44+/
CD24−/low in a dose-dependent manner (Fig. 3c, e). Con-
sistently, after treatment with NC for 48  h, a decreased 
expression of CD44 protein was observed (Fig.  3d). 
Fig. 3 NC decreases the CSCs-like properties of breast cancer cells. NC inhibited mammosphere formation of MDA-MB-468 (a) and MCF-7 (b) cell 
lines. NC reduced the number of mammospheres after 7 days of treatment. Smaller sizes of mammospheres were observed in comparison with 
control. Representative images of spheres were shown above. The MDA-MB-468 and MCF-7 cells were treated with increasing concentrations of NC 
(0, 1.0 to 2.5 μM) for 48 h. c flow cytometry was used to detect cell surface markers. A set of representative flow cytometry plots was shown above. 
e NC significantly suppressed the number of both cells expressing CD44+/CD24−/low in a dose-dependent manner. d The expressions of CD44 were 
observed by western blotting. f The expressions of Oct-4, Nestin, and Nanog were determined by real-time PCR with GAPDH as a loading control. 
Experiments were independently repeated at least three times
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Moreover, formation of spheroids demonstrates cellu-
lar capacity for self-renewal and for initiation of tumors, 
both of which are characteristics of cancer stem cells 
(CSCs) [23]. We then investigated the effects of NC on 
the formation of spheroids in breast cancer cells. In non-
adherent dishes, breast cancer cells formed free-floating 
and viable of spheres; however, after 48 h NC treatment, 
such characteristics of these cells were abolished. As 
shown in Fig.  3a, b, not only was the volume of mam-
mospheres significantly reduced, but the number of 
mammospheres was significantly declined in time-and 
does- manner. These results were consistent with those 
from the MTT assay.
As is known, Nanog, Nestin and Oct-4 are required for 
maintaining pluripotency in stem cells [24, 25]. There-
fore, we further examined the effects of NC on these 
factors. As shown in Fig.  3f, the expression levels of 
Nanog, Nestin and Oct-4 were inhibited by NC in a dose-
dependent way. These data demonstrated that NC could 
decrease the CSCs like properties of breast cancer cells.
NC inhibited Hedgehog signaling pathway
The Hedgehog (Hh) signaling pathway is definitely essen-
tial for the development of tissues and organs [26]. How-
ever, aberrant activation of Hedgehog signaling pathway 
plays important roles in tumorigenesis and progression 
of several tumors [27]. We hypothesized that Hedgehog 
signaling pathway might as well be implicated in the NC-
induced inhibition of EMT and CSCs-like properties in 
both breast cancer cells. We first sought to examine the 
effects of NC on Hedgehog pathway by measuring the 
expression of Hh receptors (Patch, Smo) and effectors 
(Gli1, Gli2) by western blot (Fig. 4a). As shown in Fig. 4b, 
NC downregulated the expression of Smo and Patch. 
Similarly, NC inhibited the expression of transcription 
factor Gli1 and Gli2, and its inhibition effecton Gli1 
expression was much more significant than Gli2. Then, 
we examined the effects of NC on mRNA expression of 
Gli1 and Smo by RT-PCR in breast cancer cell line MDA-
MB-468 and MCF-7. As shown in Fig. 4c, NC inhibited 
the mRNA expression of Gli1 and Smo in these cells as 
well, suggesting that NC could inhibit the activation of 
Hh signaling in breast cancer.
Hedgehog were involved in the NC‑induced inhibition 
of EMT and CSCs‑like properties
To further confirm whether NC is Hedgehog dependent, 
we inhibited Hedgehog pathway using the Smo inhibi-
tor Cyclopamine [28, 29]. After pretreatment of MDA-
MB-468 and MCF-7 cells with 10  μM of Cyclopamine 
for 6 h, both cells were subject to 0 or 1.0 μM of NC for 
48 h respectively. We found that in both presence of NC 
and Cyclopamine the migratory capacity of breast cancer 
cells was further decreased, compared to the treatment 
of NC only (Fig. 5a). As shown in Fig. 5a, c, blockade of 
Hh signaling pathway by Cyclopamine could significantly 
enhance NC-induced inhibition of Hh and Gli1 expres-
sion as well as inhibition of migration of breast cancer 
cells. It has been reported that Snail induction and E-cad-
herin suppression were early responses to Gli1 overex-
pression [30], which is similar to our following results 
that Cyclopamine could down-regulate N-cadherin and 
Vimentin expression and up-regulate E-cadherin expres-
sion induced by NC (Fig. 5c).
Emerging data from many human tumors have mani-
fested that Hedgehog–Gli1 signaling could regulate CSCs 
activities [31]. Furthermore, we observed the effects of 
Hedgehog on NC-induced inhibition of CSCs-like prop-
erties in breast cells, and cells were treated as described 
above. NC could inhibit the formation of spheroids in 
our present study. However, inhibition of Hh pathway 
could enhance the effect above induced by NC (Fig. 5b). 
As shown in Fig.  5c, Cyclopamine inhibited the expres-
sion of Smo and further attenuated the expression of 
transcription factor Gli1. Interestingly, in the presence 
of Cyclopamine and NC, inhibition of Hh-Gli1could 
further decrease the expression of CSCs related marker 
CD44 compared to the NC alone. These results indicated 
that Hedgehog was involved in NC-induced inhibition of 
EMT and CSCs-like properties in breast cancer cells.
NC suppressed TGF‑β1 induced EMT and CSC of breast 
cancer cells
Previous studies have revealed that TGF-β plays a criti-
cal role in driving EMT process in the pathogenesis of 
breast cancer [32, 33]. We next examined whether NC 
could inhibit TGF-β1 induced EMT, which is associated 
with cellular migratory and invasive ability. Morpho-
logical changes of MDA-MB-468 and MCF-7 cells after 
TGF-β1 treatment were followed in the absence or pres-
ence of NC, which was observed by optical and confocal 
microscopy. As shown in Fig. 6a, addition of TGF-β1 at 
concentration of 5  ng/ml for 72  h altered the morphol-
ogy of both cells from an epithelial phenotype to a clas-
sical mesenchymal phenotype. Cells treated with 5  ng/
ml TGF-β1 and 2.5 μM NC displayed classical epithelial 
morphology. The breast cancer cell line has been demon-
strated to undergo EMT process in response to TGF-β1 
stimulation [34]. To ensure whether this is also the case 
for MDA-MB-468 and MCF-7, we assessed the expres-
sion of various EMT-associated markers and the CSC-
related markers after 7 d and 10 d treatment with TGF-β1 
(Fig. 6b).
To further confirm the effect of NC on TGF-β1 induced 
EMT and CSCs properties, we determined the expression 
levels of EMT related marks after the cells were treated 
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with 5 ng/ml TGF-β1 with or without 2.5 μM of NC. As 
shown in Fig. 6c, TGF-β1 up-regulated the mRNA level 
of N-cadherin and Vimentin as mesenchymal marker. 
NC significantly reversed all of these TGF-β1 induced 
effects. EMT is thought to be a prerequisite for tumor 
cells to become motile and eventually more invasive and 
metastatic. In order to determine the potential role of 
NC in cellular metastasis of breast cancer by inhibiting 
TGF-β1-induced EMT, transwell assays were conducted 
to observe the effects of NC on cell migration. The results 
showed that TGF-β1 markedly enhanced the migratory 
ability of the cells (Fig. 6d), and NC reversed these effects. 
To evaluate the effects of NC on the expression of E-cad-
herin, N-cadherin, Vimentin, Snail and CD44 at protein 
level, we determined these proteins in MDA-MB-468 and 
MCF-7 cells with or without NC using Western blotting. 
As shown in Fig.  6e, NC could down-regulate protein 
expressions of TGF-β1 induced EMT and CSC related 
markers, and the trend was consistent with the mRNA 
results. Taken together, our results demonstrated that 
NC could suppress TGF-β1 induced EMT and CSC in 
both breast cancer cells.
Discussion
NC has recently received more attention for its pleio-
tropic anticancer roles in inhibition of tumor angiogen-
esis, inflammatory, and inhibition of proliferation and 
metastasis [3, 5, 6, 35]. Previous evidence has suggested 
that NC has the potential to prevent breast cancer devel-
opment, for example, NC induces breast cancer cell 
apoptosis though the intrinsic, mitochondrial-depend-
ent caspase pathway [7]. In addition, combined with 
Fig. 4 NC inhibited Hedgehog pathway in MDA-MB-468 and MCF-7 cell lines. Cells were treated with various concentrations of NC for indicated 
time. a The Gli1, Gli2, Smo and Patched1 proteins were examined by western blot in both cells. b Treatment of both cell lines with NC (0, 1.0, or 
2.5 μM) for 48 h resulted in a significant inhibit the activation of Hedgehog signaling pathway in a dose-dependent manner, β-actin was used as a 
loading control. c Then, the expressions of Gli1 and Smo were determined by real-time PCR with GAPDH as a loading control. Results are presented 
as mean ± SD
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doxorubicin, NC could exhibit a synergistic inhibi-
tory effect on cellular growth of the human breast can-
cer cell lines. In the present study, we first reported that 
NC exhibited a chemotherapeutic effect against EMT 
and CSCs, and then abrogated breast cancer metastasis. 
After exposure of breast cancer cells to NC, they showed 
inhibited metastasis ability of breast cells by inhibit-
ing the expression of transcription factors (Snail, Slug 
and Zeb1) and EMT markers. What is more, NC could 
inhibit cellular CSCs-like self-renewal capacity of breast 
cancer by inhibiting the expression of pluripotency main-
taining transcription factors (Nanog, Nestin and Oct-4) 
and CSCs markers (CD44) as well as the components of 
Hh pathway. In addition, our results demonstrated that 
NC also suppressed TGF-β1 induced EMT, expression 
of CSCs-related markers as well as cellular migration 
Fig. 5 NC induced inhibition of in breast cells by Hedgehog-Gli1 pathway. After both cells were pretreated by cyclopamine (a Smo inhibitor) 
for 6 h, they were exposed to 0, 1, or 2.5 μM of NC for 48 h respectively. a Transwell assay analyses of the migratory capacity of both cells. Then 
quantification of transwell cell migration assay. b Free-floating, viable spheres formed by breast cancer cells. c Western blotting analyses of Gli1, Smo, 
E-cadherin, N-cadherin, Vimentin, CD44 levels. Blots were normalized by use of β-actin to correct for differences in loading of the proteins.*P < 0.05 
or **P < 0.01. The data are presented the mean ± SD of three separate experiments
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in both cell lines. Furthermore, we revealed that these 
effects were ascribed to the inhibition of Hedgehog path-
way by NC treatment on MDA-MB-468 and MCF-7 cells.
EMT is an available strategy to target cancer metasta-
sis, and the loss of E-cadherin and gain of Vimentin have 
been known to play vital roles in EMT process of vari-
ous malignancies, breast cancer included. The transcrip-
tional repressors including Snail, Slug, ZEB-1 and ZEB-2 
are known to downregulate E-cadherin expression [36, 
37]. Furthermore, transformed epithelial cells can acti-
vate embryonic programs of epithelial plasticity through 
switching from a sessile, epithelial phenotype to a motile, 
mesenchymal phenotype [38]. In the present study, after 
exposure of breast cancer cells to NC, they showed an 
inhibited migration and invasion ability. Further, there 
were increased expression of epithelial marker E-cad-
herin, and decreased expression of mesenchymal marker 
N-cadherin and vimentin, as well as down-regulated 
expression of Snail, Slug and Zeb1 (transcription factors). 
These results demonstrated that, with exposure to NC, 
both breast cancer cells undergo a MET.
CSC is believed to be the origin of metastatic breast 
cancer, which has the capabilities for self-renewal and 
differentiation into the bulk cancer cells [39]. Acquisition 
of CSCs-like properties emerges as a key step in cancer 
progression [40, 41]. TICs and CSCs share a variety of 
properties, including self renewal, although it is typically 
unregulated in tumor generation. Many cultured CSC 
lines form free floating spherical clusters of viable cells 
with a preponderance of the CSCs [23, 42]. In our previ-
ous study, breast cancer cells with NC treatment exhib-
ited suppressed capacity for forming tumorsphere. Many 
genes were expressed in breast CSCs, including CD44, 
ALDH etc. [43]. Nanog, Oct-4 and Nestin can co-occupy 
Fig. 6 The effects of NC on the TGF-β-induced EMT and CSCs-like properties of breast cancer cells. MDA-MB-468 and MCF-7cells were treated with 
5 ng/ml TGF-β1 with or without 2.5 μM NC for 48 h. a Cells were treated with, and the phenomenon of EMT was observed based on morphological 
changes of the cells. b The both cells were treated with5 ng/ml TGF-β for 7 d or 10 d. The expressions of EMT and CSCs-related marks were observed 
by western blotting. β-actin was used as a loading control. c Treatment with NC for 48 h diminished the effects of TGF-β1 on the expression of 
N-cadherin, Vimentin at the mRNA level in MDA-MB-468 and MCF-7cells, as determined by QT-PCR. d The effects of NC in breast cancer cell migra-
tion. The number of migrated cells was quantified by counting the number of cells from 5 random fields. e Treatment with NC for 48 h diminished 
the effects of TGF-β1 on the expression of EMT and CSCs-related marks at the protein level in both cells, as determined by western blotting
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and regulate their own promoters as well as other devel-
opmental genes with diverse functions, and they collabo-
rate to form an extensive regulatory circuitry including 
auto regulatory and feed-forward loops [44]. This study 
indicated NC could decrease CD44+/CD24−/low sub-
population and suppress the expression of Nanog, Oct-4 
and Nestin in both cell lines. In addition, expressions of 
CD44 were substantially decreased in NC-treated cells of 
MDA-MB-468 and MCF-7. These results indicated that 
breast cancer cells could lose CSCs-like characteristics 
after exposure to NC.
EMT can enrich cells with stem-like properties, while 
CSCs exhibit mesenchymal phenotypes [15, 45]. Many 
signaling pathways, including Hedgehog, Notch and Wnt, 
are believed involving in the maintenance of EMT and 
CSCs [8]. The Hh signaling pathway has been reported 
to be associated with cellular migration, invasion and 
self-renewal ability in several types of cancers [46, 47]. 
Hh signaling is activated by binding the secreted Hh pep-
tide to the 12-span transmembrane spanning receptors 
(Ptch), resulting in loss of Ptch activity and consequent 
phosphorylation and post transcriptional stabilization 
of smoothened (Smo) [48, 49]. As a result, expression of 
Hh target genes is initialized through posttranslational 
activation of the Gli family of zinc-finger transcription 
factors (Gli1, Gli2, and Gli3) [30]. Our previous study 
has demonstrated that Hedgehog pathway could play a 
crucial role in the maintenance of breast CSC properties 
[21]. In this study, we observed the inhibitory effects of 
canonical Hedgehog signaling pathway after NC treat-
ment, which was supported by decreased protein expres-
sion of transcription activator Gli1 and receptor Patch, 
and target genes of the Hh signaling pathway. To confirm 
the effect of NC on Hh, we blocked Hedgehog pathway 
in both cell lines using the Hedgehog inhibitor Cyclopa-
mine, which inhibited Hh signaling pathway by binding 
to Smo. Subsequently, Cyclopamine blocked the func-
tions of Gli1 activators, consistent with the expected 
down-regulation of the Hh–Gli1 Pathway. Further, we 
found that Cyclopamine could enhance NC-induced 
reversion of EMT and attenuation of CSC characteristics, 
as indicated by migration, mammospheres and western 
blot analysis. Here we found that the Hedgehog path-
way was also involved in NC-induced inhibition of EMT 
capacity and CSCs-like properties in breast cancer cells.
In human breast cancer, the CD44+/CD24−/low CSCs 
signature was linked with a mesenchymal, migratory 
phenotype. Even more, TGF-β induced EMT may ren-
der breast cancer cells with properties of stem cells and 
even therapy resistance [15, 50]. The TGF-β growth fac-
tor plays a complex and important role in EMT induction 
via canonical and noncanonical TGF-β signaling systems 
[40]. During the process of cancer metastasis, tumor cells, 
that metastasize, acquire capabilities of self-renewal, 
similar to which exhibit in stem cells in order to spread 
the metastases [37]. In agreement with previous reports 
[51, 52], we showed that TGF-β1 could induce EMT in 
MDA-MB-468 and MCF-7 cells, which included acqui-
sition of mesenchymal phenotype, decreased expression 
of epithelial markers E-cadherin and increased expres-
sion of mesenchymal marker Vimentin and N-cadherin, 
as well as increased expression of CSC markers such as 
CD44. Similar results could be observed while detecting 
the E-cadherin and Vimentin mRNA levels by RT-PCR. 
Moreover, we found that NC could inhibit exogenous 
TGF-β1-induced EMT and migration, accompanied 
with the decreasing expression of EMT and CSC-related 
markers in breast cancer cells.
Conclusions
As summarized in Fig.  7, our studies revealed a novel 
mechanism involving NC targeting breast cancer metas-
tasis, in which inactivation of Hedgehog signaling path-
way by NC treatment led to a significant decreased 
expression of Smo and Gli1. Suppression of Hh-Gli1 
pathway could not only directly reverse EMT, but also 
inhibit CD44 expression and abolish CSC properties. 
Furthermore, we reported that the induction of EMT by 
TGF-β1 treatment in parent breast cancer cells resulted 
in the acquisition of mesenchymal morphology and 
Fig. 7 Hedgehog pathway is involved in NC-induced inhibition of 
EMT and CSCs-like properties in breast cancer cells. In MDA-MB-468 
and MCF-7 cells exposed to NC, the schematic picture shows the 
effects of NC dual-blocking EMT and CSCs-like properties and then 
targeting breast cancer migration and invasion through inactivation 
of Hedgehog signaling
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up-regulation of the expression of CSCs markers. Moreo-
ver, our study showed that NC could also inhibit TGF-
β1-induced breast cancer cell metastasis. Therefore, our 
findings demonstrated that NC could be a novel poten-
tial agent for prevention and treatment of breast cancer 
through dual-blocking EMT and CSCs-like properties.
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